Radio and PodcastLive Radio & PodcastsOpening Radio and Podcast...
Radio and PodcastLive Radio & PodcastsFetching podcast shows and categories...
Radio and PodcastLive Radio & PodcastsFetching podcast episodes...
A monthly podcast highlighting the most important news developments and its impact on the orphan drug, cell and gene therapy world. Visit www.partners4access.com/podcasts/
One of the most persistent barriers in rare disease drug development isn’t the science — it’s identifying and reaching the small number of p...
Rare Disease Day Special | Let’s Talk Rare This Rare Disease Day, Let’s Talk Rare releases a special episode focused on the data and real-wo...
26 isn’t just another year in market access — it’s a turning point. In this episode of Let’s Talk Rare , P4A dives into the trends that are...
In this episode of Let’s Talk Rare , we looked back at P4A’s recent trip to Glasgow, where our colleagues, Sam Morrison & Iro Malekou were o...
Recorded live from ESMO 2025, Conversations Beyond the Clinic explores the different perspectives of the attendees and stakeholders at the E...
In this episode, we tune into the unfiltered voices of patients and caregivers navigating life with rare conditions. Through the power of so...
How do we make sure patients receive health information that is clear, trustworthy, and truly helpful? We sit down with Catherine Richards G...
Join us as we sit down with Paul Romness of OS Therapies to explore an exciting breakthrough in OST-HER2 targeted therapies for osteosarcoma...
Discover how artificial intelligence is transforming the future of rare disease research in the latest episode of Let’s Talk Rare , the offi...
In the latest episode of Let's Talk Rare, Owen Bryant & Georgie Rack delve into the world of drug development in rare diseases. They are joi...
Brain cancers are notoriously difficult to manage with current treatments offering limited effectiveness. But what if there was a way to cha...
Dive into P4A's annual appraisal of the year ahead. In this episode of Let's Talk Rare we examine the most important trends as identified an...
After3 years in the making, the Joint Clinical Assessment for the EU is in effect. From 12th January 2025 new cancer medicines and advanced...
Welcome to this month's P4A Let’s Talk Rare podcast episode by Partners4Acess . Today, Georgie and Owen are joined by Leonard Mazur , CEO of...
In this episode of P4A Let's Talk Rare , hosts Georgie and Owen Bryant from Partners For Access are joined by Wes Michael , founder and pres...
Welcome to this month's episode of the P4A Let’s Talk Rare podcast by Partners4Acess. Today, Georgie and Owen are joined by their colleagues...
Welcome to this month's episode of the P4A Let’s Talk Rare podcast by Partners4Acess. Today, Georgie and Owen are joined by their colleagues...
Welcome to this month's episode of Let’s Talk Rare: The Life Science Podcast brought to you by Partners4Access. Host Georgie records this ep...
Welcome to this month's episode of the Let’s Talk Rare: The Life Science Podcast by Partners4Acess. Georgie and Owen are joined by Nick Mead...
Hello and welcome to this special episode of Let’s Talk Rare: The Life Science Podcast as we celebrate 5 years of bringing you the podcast t...
In this podcast, Georgie, RJ, and Owen discuss revolutionizing patient outcomes and the power of digital health solutions. RJ, a healthcare...
Welcome to this month's episode of the Let’s Talk Rare podcast by Partners4Acess. Georgie and Owen are joined by Iola Forster , Head of Publ...
Welcome to this month's episode of the Let’s Talk Rare podcast brought to you by Partners4Acess. Georgie and Owen are joined by Chloe Sheppa...
In this episode we will be talking to Alejandro (Alex) Dorenbaum, M.D. , CMO of Reneo Pharmaceuticals . Alex discusses how the company is de...
P4A are joined by Xortx Therapeutics' CEO, Dr Allen Davidoff, as he discusses the journey from early development to potential launch for the...
P4A host a special episode live from World Evidence, Pricing & Access Conference 2023 in Amsterdam. Join Georgie & Owen hosting live from Wo...
In this episode of Let’s Talk Rare, as we commemorate World Rare Disease Day, Georgie and Owen are joined by Louise Fish and Dan Lewi to dis...
The P4A team have hand-picked trends to look out for in 2023. This episode we are joined by special guest Neil Grubert who will be discussin...
Did you miss the World Orphan Drug Congress Europe 2022, held in Sitges, Barcelona in November? If you did, don't worry P4A have you covered...
Winds of change are howling in Germany, with the draft healthcare bill now approved to stabilise SHI fund finances. What will manufacturers,...
P4A’s 2 part -Patient Empowerment podcast series has been released. Our incredible panel of experts Laurence Woollard, Neil Bertelsen & Soph...
This month we have a special 2-part series focused on Patient Empowerment, with special guests Laurence Woollard, On the Pulse, Neil Bertels...
This month we have put together a slightly different episode with a twist. Georgie & Owen will take you behind the scenes at P4A and discuss...
In this episode Chloe & Alexander will be starting the discussion with an overview of EU HTA regulation, looking at the harmonization debate...
Part 1 featuring Victor Maertens, Government Affairs Manager at EUCOPE In this episode Victor and Aparna will be focusing on Advanced Therap...
In 2020 China’s pharmaceutical market passed an important milestone, a Deloitte report cited that China was expected to grow its pharmaceuti...
Over the last few years, the Middle East has piqued the interest of orphan drug manufacturers, and some have prioritised launching in this r...
For this Rare Disease Day episode, Janet and Nick discuss a range of topics associated with the rare disease community and patient advocacy....
Lots of anticipated changes are expected in the orphan drug, cell and gene therapy space and 2022 is going to be an exciting year. Listen to...
Sophie Schmitz and Joanna Fernandes discuss bluebird bio’s innovative gene therapy Zynteglo and its withdrawal from the European market. Sop...
This episode featuring James Mackay, President & CEO of Aristea Therapeutics. James provides insights on his experience with setting up a bi...
In this episode P4A’s Richard Wang and Adama Anozie discuss Hospital Exemption (HE) which is an emerging access pathway for Advanced Therapy...
In this episode P4A’s Senior Client Relationship Director, Bruce Chin discusses his experiences from the in person World Orphan Drug Congres...
In this episode Akshay Kumar and Richard Wang discuss how through innovative technology, decentralised clinical trials came to the limelight...
In this episode, the P4A team take a deep dive into the Brazilian pharmaceutical market and discuss its potential for access to orphan drugs...
Its almost six months since President Joe Biden came to office but the role of the head of the country's key drug regulator, the US Food and...
In this month's episode, the P4A team take a deep dive into the impact of Brexit on the UK's market access landscape. Four months after leav...
The world of orphan drugs is at the cusp of a transformation in the post COVID era. In this episode, the team discuss the impact of the pand...
In this episode, the P4A team discussed the impact of cost-containment measures in Germany, the European Commission's recent move to revise...
In this Rare Disease Day special episode, we focus on the impact of COVID -19 on rare disease patients. Some of the key challenges for patie...